This study is looking at how the medication cenobamate works in people who are having frequent seizures or a prolonged seizure (status epilepticus) in the intensive care unit (ICU). Researchers want to see if cenobamate can reach certain levels in your body to help control these seizures. You might be able to join if you are between 18 and 70 years old, are having acute frequent seizures or status epilepticus, and are already undergoing EEG monitoring. The study will measure the amount of cenobamate in your body at 6 hours after the first dose and for up to 14 days. The current status of this study is unclear, and it plans to enroll 10 patients.

Study design

This is an interventional study involving 10 patients. It is a multi-center trial, meaning it will take place at several hospitals.

What's involved

You would receive cenobamate daily for up to 14 days, or until your seizures stop or a specific safety score is reached. Your cenobamate dose may be adjusted during this time.

Compensation

Not stated in the trial record.

Follow-up

Your cenobamate levels will be monitored for up to 14 days after starting the medication.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.